Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren light-meal study in elderly patients with essential hypertension
NL-OMON31913Phase 3Active, not recruiting
- Sponsor
- Novartis
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aliskiren, sponsored by Novartis. Started Jul 2008; status: active, not recruiting.
02
Drugs
aliskiren
Beyond the preview
Go deeper on NL-OMON31913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31913.